Aggregated China Business Blogs
Chinese VC spending on US biotech hit by security reviews
India and China sign $22bn in deals
PMI dips, but still in recovery
How China broke the Asian model
Orient Securities maintains Bethel’s buy rating: performance is in line with expectations, lightweight products and BB will be new growth points, with a target price of 38.34 yuan
Questioning of UBS financier in China rattles private banks
China is no longer a bargain
Foxconn axes 50,000 seasonal jobs as Apple slowdown bites
In the first week of February, the fund first raised nearly 77 billion yuan, and 17 new products “closed” ahead of schedule! 5 funds will be issued next week-Finance-
Jinlang Technology: Shareholders holding more than 5% of the shares and their concerted actors have changed more than 1% and the time of the reduction plan is more than half-